SCA
KURA icon

Secor Capital Advisors’s Kura Oncology KURA Stock Holding History

Secor Capital Advisors’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-52,964
Closed -$744K – 496
2018
Q4 		$744K Buy
52,964
+33,722
+175% +$447K 0.1% 263
2018
Q3 		$337K Buy
+19,242
New +$369K 0.04% 360

Other funds holding KURA

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return

Secor Capital Advisors's KURA Position: Q1 2019 in Review

Secor Capital Advisors sold out of Kura Oncology (KURA) in Q1 2019, closing a stake of 52,964 shares — an estimated $744K sold.

Secor Capital Advisors first reported a position in KURA in Q3 2018 and held it in 2 quarters. The position peaked at $744K in Q4 2018. 104 funds tracked by Wall St. Rank hold KURA as of Q1 2019.

  • Secor Capital Advisors reported no remaining Kura Oncology position as of Q1 2019 after selling out during the quarter.
  • Secor Capital Advisors sold 52,964 Kura Oncology shares in Q1 2019, an estimated $744K.
  • Secor Capital Advisors first reported a position in Kura Oncology in Q3 2018 and held it in 2 quarters.
  • Secor Capital Advisors's Kura Oncology position peaked at $744K in Q4 2018.
  • 104 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2019.

Based on Secor Capital Advisors's 13F filing for Q1 2019, filed 15 May 2019.